Glyclopyramide
From Self-sufficiency
| File:Glyclopyramide.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ATC code | none |
| PubChem | CID 71793 |
| Chemical data | |
| Formula | C11H14ClN3O3S |
| Molar mass | 303.76 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.[1]
References
- ↑ Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]". Yakushigaku Zasshi (in Japanese). 38 (1): 11–27. PMID 14570054.
- (Japanese) Deamelin-S 250 mg Tablets
| 45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- CS1 maint: Unrecognized language
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Sulfonylureas
- Pyrrolidines
- Organochlorides
- Gastrointestinal system drug stubs
- 2Fix
